title: Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir.
abstract: Darunavir is currently the most recently approved HIV-1 protease inhibitor. It is approved for twice-daily dosing with ritonavir in treatment-experienced patients as young as 6 years of age and is available in numerous pill strengths. Emergence of darunavir-specific mutations is generally slow; therefore it can retain activity against viral strains that are resistant to other protease inhibitors, including tipranavir. Darunavir pharmacokinetics, clinical efficacy, resistance mutations and pharmacodynamics, and adverse effects are reviewed here. Substantial data support its use as a potent, well-tolerated option for salvage therapy in highly treatment-experienced children and adolescents.
authors.affiliation: University of Southern California, Keck School of Medicine, Department of Pediatrics, Division of infectious Diseases, Los Angeles, CA, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Neely
authors.forename: Andrea
authors.initials: A
authors.lastname: Kovacs
references.citation: Lancet. 2007 Jul 7;370(9581):49-58
references.pmid: 17617272
references.citation: AIDS. 2005 Jun 10;19(9):989-90
references.pmid: 15905684
references.citation: AIDS Res Hum Retroviruses. 2008 Mar;24(3):379-88
references.pmid: 18327986
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3123-9
references.pmid: 14506019
references.citation: AIDS. 2008 Sep 12;22(14):1809-13
references.pmid: 18690163
references.citation: Antimicrob Agents Chemother. 2005 Jun;49(6):2314-21
references.pmid: 15917527
references.citation: Antivir Ther. 2008;13(4):563-9
references.pmid: 18672535
references.citation: J Antimicrob Chemother. 2008 Jan;61(1):183-90
references.pmid: 18025025
references.citation: AIDS. 2007 Feb 19;21(4):395-402
references.pmid: 17301557
references.citation: J Clin Pharmacol. 2008 Jan;48(1):60-5
references.pmid: 18094220
references.citation: J Antimicrob Chemother. 2006 Mar;57(3):579-82
references.pmid: 16446377
references.citation: Top HIV Med. 2008 Dec;16(5):138-45
references.pmid: 19106428
references.citation: Br J Clin Pharmacol. 2008 Aug;66(2):215-21
references.pmid: 18460033
references.citation: J Clin Pharmacol. 2007 Apr;47(4):479-84
references.pmid: 17389557
references.citation: J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):192-5
references.pmid: 19131889
references.citation: Sex Transm Infect. 2003 Oct;79(5):419-21
references.pmid: 14573842
references.citation: Antimicrob Agents Chemother. 2007 Mar;51(3):958-61
references.pmid: 17210768
references.citation: Lancet. 2006 Aug 5;368(9534):476-82
references.pmid: 16890834
references.citation: AIDS. 2008 Jan 2;22(1):165-7
references.pmid: 18090413
references.citation: Antivir Ther. 2007;12(4):509-14
references.pmid: 17668559
references.citation: J Virol. 2007 Dec;81(24):13845-51
references.pmid: 17928344
references.citation: J Antimicrob Chemother. 2007 Oct;60(4):885-8
references.pmid: 17646201
references.citation: AIDS. 2008 Jul 31;22(12):1389-97
references.pmid: 18614861
references.citation: Antimicrob Agents Chemother. 2008 Nov;52(11):3928-32
references.pmid: 18725446
references.citation: Clin Drug Investig. 2008;28(8):479-85
references.pmid: 18598093
references.citation: Antivir Ther. 2008;13(6):839-43
references.pmid: 18839785
references.citation: Ann Pharmacother. 2008 Jul;42(7):1048-59
references.pmid: 18577765
references.citation: Drug Metab Dispos. 2009 Apr;37(4):809-20
references.pmid: 19131522
references.citation: Lancet. 2007 Apr 7;369(9568):1169-78
references.pmid: 17416261
references.citation: Antivir Ther. 2005;10(8):879-92
references.pmid: 16430193
references.citation: Drugs R D. 2007;8(4):241-8
references.pmid: 17596110
references.citation: AIDS Res Ther. 2007 Jul 09;4:15
references.pmid: 17620130
references.citation: Pediatr Infect Dis J. 2008 Aug;27(8):749-52
references.pmid: 18664987
references.citation: J Virol Methods. 2007 Oct;145(1):47-55
references.pmid: 17574687
references.citation: HIV Clin Trials. 2005 Mar-Apr;6(2):73-80
references.pmid: 15983891
references.citation: AIDS. 2008 Sep 12;22(14):1789-98
references.pmid: 18753862
references.citation: Antivir Ther. 2008;13(2):271-9
references.pmid: 18505178
references.citation: Ther Drug Monit. 2007 Dec;29(6):795-801
references.pmid: 18043478
references.citation: Antimicrob Agents Chemother. 2008 Feb;52(2):491-6
references.pmid: 18039922
references.citation: J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):24-31
references.pmid: 17621237